Tag Archives: VXMFF

Top 10 Low Price Stocks To Buy Right Now

Either low-income Americans became rich this Black Friday, or Wal-Mart’s (NYSE:WMT) marketers do not know what they are doing.

For years, $133,653 Cartier watches and expensive jewelry were sold in upper scale stores, where high income Americans prefer to shop on Black Friday. 

This year, Cartier watches are being sold on the Walmart.com site.

But who will buy them? Will high income Americans trade the upscale store for Wal-Mart’s site? That sounds very unlikely to me. Shopping for luxury items is usually more about the experience of shopping rather than about price.

What about Wal-Mart’s low-income shoppers? That’s unlikely, too, as they cannot afford items that sell at a hefty multiple of their annual income. Besides, some of Wal-Mart’s shoppers do not even use credit cards, so how can they purchase $133,653 watches on-line?

For more than three decades, Wal-Mart ruled the US retailing industry. Its large stores and everyday low prices were too much for smaller neighborhood stores and supermarkets. Result? They went out of business shortly after Wal-Mart invaded their turf.

Top 10 Low Price Stocks To Buy Right Now: Sony Corp Ord(SNE)

Advisors’ Opinion:

  • [By WWW.THESTREET.COM]

    Since being appointed CEO in November, Bakish has said he would focus on Paramount and MTV, both of which have lost considerable ground to rivals. Along with executive changes at many of Viacom’s networks, Bakish in December hired Gumpert from Sony (SNE) Pictures Entertainment, replacing Frederick Huntsberry, who left the company.

  • [By David Zeiler]

    One of the regime’s better-known attacks occurred in November 2014, as Sony Corp. (NYSE ADR: SNE) prepared to release “The Interview,” a film that parodied Kim Jong Un. North Korea hacked Sony Pictures Entertainment, released information it had stolen from the studio’s computer systems, and threatened terrorist attacks unless the film was pulled.

  • [By Jack Delaney]

    Here are 10 virtual reality stocks to watch in 2017, with today’s opening price (Feb. 22) and the year-to-date (YTD) return thus far:

    3D Systems Corp. (NYSE: DDD); $17.12; +26.71% YTDUniversal Display Corp. (Nasdaq: OLED); $71.60; +25.49% YTDAdvanced Micro Devices Inc. (Nasdaq: AMD); $14.30; +24.22% YTDFacebook Inc. (Nasdaq: FB); $133.60; +18.64% YTDAdobe Systems Inc. (Nasdaq: ADBE); $119.67; +15.93% YTDSony Corp. (NYSE ADR: SNE); $31.29; +11.49% YTDAlphabet Inc. (Nasdaq: GOOGL); $848; +7.49% YTDAmbarella Inc. (Nasdaq: AMBA); $57.85; +6.26% YTDMicrosoft Corp. (Nasdaq: MSFT); $64.33; +3.16% YTDRockwell Collins Inc. (NYSE: COL); $93.97; +0.97% YTD

    The virtual reality industry could reach $33.9 billion in value by 2022, which is why virtual reality stocks are more popular than ever.

  • [By Joe Tenebruso]

    15. To date, Sony (NYSE:SNE) has dominated the console wars, with sales of its PlayStation 4 recently surpassing 53 million units worldwide. That’s more than double the estimated 26 million Xbox One units Microsoft (NASDAQ:MSFT) has sold, and triple the 15 million Wii U units sold by Nintendo (NASDAQOTH:NTDOY), according to research companySuperData.

  • [By WWW.THESTREET.COM]

    For those who want a general facsimile of the pay-TV bundle and access to the largest broadcast networks, there’s Sling TV from Dish Network (DISH) , DirecTV Now from   AT&T (T) and Sony’s (SNE) PlayStation Vue. In the coming weeks, they’ll be joined by Alphabet’s (GOOGL) YouTube TV and a still unnamed pay-TV service from Hulu, the video-on-demand service controlled jointly by Disney, Comcast’s (CMCSA) NBCUniversal and 21st Century Fox (FOXA) , along with Time Warner (TWX) holding a 10% stake.

Top 10 Low Price Stocks To Buy Right Now: PAR Technology Corporation(PAR)

Advisors’ Opinion:

  • [By Lisa Levin]

    PAR Technology Corporation (NYSE: PAR) shares were also up, gaining 15 percent to $6.59. Par Technology reported Q4 adjusted earnings of $0.13 per share on revenue of $56.8 million.

  • [By Lisa Levin]

    On Tuesday, technology shares gained by 1.61 percent. Meanwhile, top gainers in the sector included Himax Technologies, Inc. (ADR) (NASDAQ: HIMX), up 13 percent, and PAR Technology Corporation (NYSE: PAR), up 9 percent.

Top 10 Low Price Stocks To Buy Right Now: Apple Hospitality REIT, Inc.(APLE)

Advisors’ Opinion:

  • [By Lee Jackson]

    Apple Hospitality REIT Inc. (NYSE: APLE) owns one of the largest portfolios of upscale, select-service hotels in the United States.Investors are paid a generous 6.67% yield. The shares traded at $17.95 early Thursday, in a 52-week range of $16.72 to $21.90.The consensus price objective is $19.25.

  • [By Lisa Levin]

    Here is the list of stocks going ex-dividend on Monday.

    AptarGroup, Inc. (NYSE: ATR) – $0.3200 dividend, 1.6780 percent yield. AptarGroup reported weaker-than-expected Q3 results on Thursday.
    Fidelity Southern Corporation (NASDAQ: LION) – $0.1200 dividend, 2.6359 percent yield. The company, based in Atlanta, Georgia, provides financial products and services for customers.
    Apple Hospitality REIT Inc (NYSE: APLE) – $0.1000 dividend, 6.5826 percent yield. Apple Hospitality REIT, based in Richmond, Virginia, operates as a subsidiary of Apple REIT Companies.
    Targa Resources Corp (NYSE: TRGP) – $0.9100 dividend, 7.7299 percent yield. The Houston, Texas-based company provides midstream natura

Top 10 Low Price Stocks To Buy Right Now: Juniper Pharmaceuticals, Inc.(JNP)

Advisors’ Opinion:

  • [By Jim Robertson]

    On Monday, our Under the Radar Moversnewsletter suggested shorting women’s health stock Juniper Pharmaceuticals (NASDAQ: JNP):

    Juniper Pharmaceuticals shares have yet to break under a key support level at $5.00. But, waiting until that happens may be too late. After some continued testing of that floor, if-and-when the support should break, the ensuing selloff could materialize in a hurry. If you’re not it at the time it happens, you may not be able to get in at a decent price.

  • [By Jim Robertson]

    On Thursday, our Under the Radar Moversnewsletter suggested shorting small cap women’s health therapeutic stock Juniper Pharmaceuticals (NASDAQ: JNP):

Top 10 Low Price Stocks To Buy Right Now: Brady Corporation(BRC)

Advisors’ Opinion:

  • [By Shauna O’Brien]

    Robert Baird announced on Friday that it has cut its rating on Brady Corp (BRC).

    The firm has downgraded BRC from “Outperform” to “Neutral,” and has given the company a $33 price target. This price target suggests a 8% upside from the stock’s current price of $30.52.

    Analysts see the company’s WPS segment growing faster than expected.

    Brady shares were mostly flat during pre-market trading Friday. The stock is down 9% YTD.

  • [By Michael Flannelly]

    Before the opening bell on Thursday, identification solutions provider Brady Corp (BRC) posted a loss in the fourth quarter, despite a rise in revenues, as it was negatively impacted by a number of charges. However, excluding these charges, the company was able to top Wall Street analysts’ earnings and sales estimates. Nonetheless, BRC shares are plummeting in Thursday’s trading.

    The Milwaukee, Wisconsin-based company posted a loss from continuing operations of $176.2 million, or $3.41 per share, in the fourth quarter, versus last year’s fourth quarter earnings from continuing operations of $20.9 million, or 40 cents per share. Furthermore, Brady posted a net loss of $177.2 million, or $3.43 per share, compared to net earnings of $11.6 million, or 22 cents per share, in the same period a year ago.

    The fourth quarter loss includes non-cash impairment charges of $204.4 million, $15.6 million in restructuring charges, and $4 million in acquisition-related charges. Excluding these charges, Brady Corp said earnings would have been 53 cents per share in the quarter. According to analysts polled by Thomson Reuters, the company was expected to earn an adjusted 51 cents per share in the fourth quarter.

    The company’s fourth quarter sales came in at $309.1 million, up 15% from $269.1 million in sales posted last year. On average, analysts were expecting the company to see $307.13 million in revenues for the quarter.

    Looking ahead, Brady Corp. sees fiscal 2014 earnings coming in between $1.80 and $2.00 per share, below the analysts’ view of $2.30 per share.

    Brady Corp shares were down $1.71, or 5.25%, during early morning trading on Thursday. The stock is up 7.93% year-to-date.

  • [By Mike Deane]

    For the 28th year in a row, Brady Corp (BRC) has increased its dividend payout to investors.

    The Milwaukee, WI-based company increased its quarterly dividend to 19.5 cents from 19 cents, an increase of 2.6%. The annual dividend now stands at 78 cents. The quarterly dividend will be paid on October 31st, 2013 to all shareholders of record on October 10, 2013.

    BRC shares were down 40 cents, or 1.23%, by market close on Wednesday. YTD, the company’s stock is down over 4%.

Top 10 Low Price Stocks To Buy Right Now: Cipher Pharmaceuticals Inc.(CPHR)

Advisors’ Opinion:

  • [By Benzinga News Desk]

    Cipher Pharmaceuticals (NASDAQ: CPHR) is said to have hired an investment bank to explore strategic alternatives, according to sources as reported by Reuters on Monday. The sources said a potential sale of the Canada-based company is being considered. Cipher declined comment on the report.

Top 10 Low Price Stocks To Buy Right Now: VEXIM EUR0.10 (VXMFF)

Advisors’ Opinion:

  • [By SEEKINGALPHA.COM]

    French medical device maker Vexim (OTC:VXMFF) contracted with an unnamed China lab to begin China registration studies for its vertebral fracture repair device, SpineJack庐. Vexim recently was granted patents for the device in China and Japan. SpineJack is an implant designed to repair a fractured vertebra and restore spinal cord balance. The 30 minute procedure is useful in 95% of vertebral fractures, according to Vexim. SpineJack was CE marked for EU use in 2010 and now is indicated for trauma and other vertebral fractures.

Top 10 Low Price Stocks To Buy Right Now: Mercury Systems Inc(MRCY)

Advisors’ Opinion:

  • [By Lisa Levin]

    Mercury Systems Inc (NASDAQ: MRCY) shares shot up 15 percent to $19.00 after the company agreed to acquire the embedded security, RF and Microwave and custom microelectronics businesses of Microsemi Corporation (NASDAQ: MSCC).

  • [By Lisa Levin]

    Mercury Systems Inc (NASDAQ: MRCY) shares shot up 15 percent to $18.94 after the company agreed to acquire the embedded security, RF and Microwave and custom microelectronics businesses of Microsemi Corporation (NASDAQ: MSCC).

Top 10 Low Price Stocks To Buy Right Now: Radient Technologies (RTI)

Advisors’ Opinion:

  • [By Matthew Briar]

    Although the past several years have been very good ones for the cannabis — marijuana and hemp — industry, it’s still mostly being done in an old, artisan-style fashion. Most companies haven’t figured out a way of scaling up their outputs by improving their operating/production efficiency, even though the market’s growth has merited. Radient Technologies Inc (CVE:RTI) represents that next evolution of the cannabinoid business, introducing a new approach to extracting cannabinoids from cannabis plants that will not only improve yields, but create a superior, purer product.

    Canada-based Radient Technologies has developed — and patented – an ingredient-extraction process called microwave assisted processing, or “MAP,” for short. As the name implies, the use of radio microwaves helps the extraction process along. To fully appreciate why it matters, however, one has look at the approach other ingredients suppliers are utilizing now.

    With current approaches to create ingredients from an appropriate source, the material with the target compound or molecule in it is soaked in a solvent, heated to 50 degrees Celsius (or more), and over the course of several hours, the desired ingredient diffuses into the solvent. After filtration, drying, and other processing, that ingredient is finally isolated and then collected.

    It works, but it’s hardly ideal. Aside from the fact that this technique doesn’t work very well at large scale, yields are relatively low. Worse, a lot of things you don’t want to extract can still be found in the extract, lowering the quality and purity of the ingredient.

    Radient Technologies’ microwave assisted processing changes all of this.

    Using its patented MAP process, Radient is able to selectively deposit microwave energy into a biomass (source material) and heat the target elements while leaving other materials in the mix unaltered. The near-instantaneous “in-core” heating that occurs creates pressure which

  • [By James E. Brumley]

    Some of the stories about how cannabis has changed lives for the better are nothing less than astounding. Take Illinois resident Darren Miller as an example. In 2015 Miller was diagnosed with lung cancer that was later deemed terminal. Miller underwent chemotherapy, without much hope, but also began using high-THC Indica cannabis oil. Miller is alive today, and arguably shouldn’t be.

    Then there’s Floridian Branden Petro. Not only does Petro suffer epilepsy, he commonly experiences seizures stemming from the condition. Nothing has stopped the seizures as quickly or effectively as 200 milligram worth of THC cannabis oil, administered as a nasal spray. Within 20 seconds of using it, it’s as of the seizure never happened.

    And there are millions of other such (and less dramatic) examples, all pointing in the same direction – cannabis has medical value on multiple fronts. Not facilitating its commercialization is a wasted opportunity.

    It’s a notion that’s far from lost on the people that have built Canadian-based Radient Technologies Inc (CVE:RTI) from the round up, recently inking a deal with supplier of cannabinoid extracts, Aurora Cannabis.

    It’s a real accolade. Aurora is one of the largest licensed producers of medical cannabis under Health Canada’s Access to Cannabis for Medical Purposes Regulations (ACMPR), and recently began construction on an unprecedented 800,000 square foot production facility in Leduc County, Alberta. This facility, known as “Aurora Sky”, is anticipated to be capable of producing in excess of 100,000 kg of high-quality, low-cost marijuana per year.

    In most regards though, Radient Technologies is the big winner of the deal, as the partnership is apt to put its high-tech facility in full demand, helping to advance the advent of cannabis in all its potential glory.

    It’s a rather amazing science, really. Radient Technologies uses an ingredient-extraction process called microwave assisted proc

  • [By Matthew Briar]

    There’s an old business adage…. it’s not so much what you know, but who you know. If that’ s truly the case (and it is), then shareholders in Radient Technologies Inc (CVE:RTI) should be elated. The newest member of the Board of Directors that not already knows a lot of the right people, but has pretty much done all of things Radient would like to accomplish in the near future. That is, he was on the board for another ingredient and chemical company that was eventually acquired, but he also holds a masters degree in engineering. He can do it all, understanding the art and science of the business.

    It’s yet another reason for RTI investors to be enthused.

    Radient Technologies isn’t exactly a new company, but it’s relative notoriety is a fairly new phenomenon.

    The organization, in simplest terms, has developed an ingredient-extraction process called microwave assisted processing, or “MAP,” for short. As the name implies, the use of radio microwaves helps the extraction process along.

    Using its patented MAP process, Radient is able to selectively deposit microwave energy into a biomass (source material) and heat the target elements while leaving other materials in the mix unaltered. The near-instantaneous “in-core” heating that occurs creates pressure which drives out the targeting ingredient or component much faster than more conventional extraction methods. In fact, the pressure-driven process outperforms the conventional extraction on pretty much every front. That is, the technique reduces the extraction time from hours to minutes, delivers a higher active ingredient purity, increases the recovery of actives from often scarce biomass, and uses much less solvent and energy than the more typical approach.

    The technique can, and already has, created natural ingredients for global customers across a range of industries, including food and beverage, nutrition, supplements, pharmaceuticals and cosmetics.

    The company’

  • [By Matthew Briar]

    At first glance, a new set of rules from the Drug Enforcement Agency unveiled in the middle of December looked like it posed a problem for cannabis-newcomer Radient Technologies Inc (CVE:RTI). By assigning a controlled substances code number to ‘marijuana extract,’ simultaneously distinguishing (and acknowledging the differences of marijuana, hemp and their derivatives as Schedule I substances. As the ruling’s language explained, “This code number will allow DEA and DEA-registered entities to track quantities of this material separately from quantities of marihuana. This, in turn, will aid in complying with relevant treaty provisions.”

    It presents something of an uncertainty, as it was not clear of the DEA also meant hemp and cannabis extracts when it used the term ‘marijuana extract.’ After all, the Drug Enforcement Agency has thus far done a poor job of distinguishing between hemp and marijuana, but has generally erred on the side of grouping everything as marijuana…. even if it didn’t cause a ‘high,’ and even if it did provide a medical benefit. If that was indeed the case, Radient Technologies may well be a non-starter in its quest to get into the cannabis business.

    No need to worry. Though it took weeks to get some much-needed clarification, the DEA has finally explained what it was saying two months ago. Indeed, the new ruling may actually help the medical marijuana — cannabis — along. DEA spokesman Russ Baer said in an e-mail to The Cannabist, “(The rule change) recognizes that there is a potential medical benefit to some of the cannabinoids.”

    Some still worry the wording of the law essentially, even if unintentionally, puts cannabinoids (or CBD) under the purveyance of the DEA; it’s currently not. Even so, if nothing else the ruling has the government moving towards clarity, after acknowledging CBD — the healthy version of the cannabis, and not the one that gets you high — has medical value. The next step is clarifying ho

  • [By Bryan Murphy]

    It’s been a long time in the coming, but there’s no denying the tipping point has been reached — cannabinoids are the foundation for a whole new kind of medicine. And, the work-to-date turning cannabis into pharmaceuticals has been very encouraging.

    Problem: While the premise of cannabinoids as drugs has been validated, the science of creating large quantities of pure cannabinoids remains more ineffective than effective. Radient Technologies Inc (CVE:RTI) is about the change that, leveraging a means of extracting a lot of cannabinoid material from a source, and ensuring the highest-level of purity and quality.

    Radient Technologies manufactures natural ingredients for global customers across a range of industries, including food and beverage, nutrition, supplements, pharmaceuticals and cosmetics. Using a proprietary, patented technology, Radient’s products are superior in quality and purity while manufactured at a significantly lower cost than other methods thanks to superior yields and efficiency.

    To fully appreciate the science Radient has developed, however, one must understand the alternative methods currently employed.

    With current approaches to create ingredients from an appropriate source, the material with the target compound or molecule in it is soaked in a solvent, heated, and then over the course of several hours the desired ingredient diffuses into the solvent. After filtration, drying, and other processing, that ingredient is finally isolated and then collected.

    It works, but it’s far from ideal. Aside from the fact that this technique doesn’t work very well at large scale, yields are relatively low. Worse, many undesirable components can still be found in the extract, lowering the quality and purity of the ingredient.

    Radient Technologies uses an ingredient-extraction process called microwave assisted processing, or “MAP,” for short.

    Using its patented MAP process, Radient is able to selectiv

  • [By Jim Robertson]

    Small cap Radient Technologies (CVE: RTI) is focused on extracting, isolating and purifying food/nutraceutical ingredients (colourings, flavourings, preservatives etc) and pharmaceutical raw materials from its20,000 square foot manufacturing plant in Edmonton, Alberta. The Companyworks with global brands across a range of industries (including Food and Beverage, Nutrition and Supplements, Pharmaceuticals, Personal Care and Cosmetics and Biofuel) andengageswithits clients in three distinct phases:

Top 10 Low Price Stocks To Buy Right Now: Access National Corporation(ANCX)

Advisors’ Opinion:

  • [By Jim Robertson]

    Today, ourunder the Radar Moversnewsletter suggestedshorting small cap Northern Virginia based bank holding stock Access National Corporation (NASDAQ: ANCX):

Best Undervalued Stocks To Invest In 2019

A quick note: With the 280+ comments I received on my piece published over the weekend about selling a portion of your Apple (NASDAQ:AAPL) stock, I wanted to further clarify my position as the context is important in reading this piece. Unfortunately, many I fear read the title and glossed over the article before commenting, albeit insightful and informative commentary.

My main thesis was: generate a handsome profit by selling a portion (1% up to whatever you are comfortable with) of your current Apple position, because with the current Q1 numbers and future uncertainty in the hardware world, there are more undervalued stocks out there to “seek alpha.”

Unfortunately the title, “Consider Selling a Portion of Your Apple Stock to Capture Gains and Reinvest in Undervalued Sectors for Higher Probability of Alpha” – was not fit to print. And because I’m all about equal opportunity, I’ve written a strategy to make money off naysayers like me! Now onto your regularly scheduled programming

Best Undervalued Stocks To Invest In 2019: Marsh & McLennan Companies, Inc.(MMC)

Advisors’ Opinion:

  • [By Reuters]

    Wendy Maeda/The Boston Globe via Getty Images
    NEW YORK — Walgreen is moving 120,000 employees to a private health insurance exchange from coverage provided directly from carriers, the company will announce Wednesday.
    The pharmacy chain will join 17 other large employers on the Aon Hewitt Corporate Health Exchange as part of a growing movement to offer employees fixed dollar amounts to purchase their own plans on such exchanges.
    The end-cost to employees depends on the plan chosen, but they typically get more options than under traditional arrangements. Private exchanges mimic the coverage mandated as part of the Affordable Care Act. Enrollment in the public exchanges starts Oct. 1.
    “What happens to employer contributions over time? Will they put in as much as they put in the past? These are unanswered questions but potential negatives,” says Paul Fronstin, a senior research associate with the Employee Benefit Research Institute. The benefit to Walgreen and other employers is unknown at this point, as their cost-savings aren’t clear.
    Of the 180,000 Walgreen (WAG) employees eligible for health care insurance, 120,000 opted for coverage for themselves and 40,000 family members. Another 60,000 employees, many of them working part-time, weren’t eligible for health insurance.
    Aon Hewitt (AON) says other participants in its program include retailer Sears Holding (SHLD) and Darden Restaurants (DRI). These new additions raise enrollment to 330,000 from 100,000 last year, and Aon Hewitt estimates enrollment will jump to 600,000 next year, a fivefold increase from 2012.
    By 2017, nearly 20 percent of employees nationwide could get their health insurance through a private exchange, according to Accenture Research (ACN). A recent report by the National Business Group on Health said that 30 percent of large employers are considering moving active employees to exchanges by 2015.

    Other major providers of private exchanges include Mercer, a division of Marsh & Mc

Best Undervalued Stocks To Invest In 2019: WildHorse Resource Development Corporation (WRD)

Advisors’ Opinion:

  • [By Paul Ausick]

    WildHorse Resource Development Corp. (NYSE: WRD) raised $413 million on the sale of $27.5 million at $15 per share, well below the expected range of $19 to $21. Shares popped just 0.4% for the day and closed the week down 0.9%.

Best Undervalued Stocks To Invest In 2019: Plantronics Inc.(PLT)

Advisors’ Opinion:

  • [By Lisa Levin]

    Shares of Plantronics Inc (NYSE: PLT) were down 25 percent to $33.36. Plantronics reported better-than-expected third-quarter earnings, but the company’s revenue missed analysts’ expectations. The company announced a new 1 million share buyback plan and issued a weak earnings forecast for the fourth quarter.

  • [By Joseph Griffin]

    TRADEMARK VIOLATION NOTICE: “Brian S. Dexheimer Sells 500 Shares of Plantronics (PLT) Stock” was originally posted by Ticker Report and is the sole property of of Ticker Report. If you are reading this piece on another publication, it was illegally copied and republished in violation of US and international copyright & trademark law. The original version of this piece can be accessed at www.tickerreport.com/banking-finance/3355123/brian-s-dexheimer-sells-500-shares-of-plantronics-plt-stock.html.

Best Undervalued Stocks To Invest In 2019: Caleres, Inc.(CAL)

Advisors’ Opinion:

  • [By Lisa Levin] Related CRMD Mid-Day Market Update: U.S. Stocks Turn Negative; AveXis Shares Spike Higher 12 Biggest Mid-Day Gainers For Tuesday CorMedix's (CRMD) CEO Khoso Baluch on Q4 2016 Results – Earnings Call Transcript (Seeking Alpha)
    Related BIOA Mid-Day Market Update: U.S. Stocks Turn Negative; AveXis Shares Spike Higher Mid-Morning Market Update: Markets Edge Higher; Tiffany Earnings Top Estimates BioAmber (BIOA) Q4 2016 Results – Earnings Call Transcript (Seeking Alpha)
    CorMedix Inc. (NYSE: CRMD) shares fell 27.5 percent to $1.50 after the company reported Q4 results and issued a business update.
    Bioamber Inc (NYSE: BIOA) shares tumbled 23.6 percent to $2.40. BioAmber reported FY16 adjusted loss of $1.07 per share on revenue of $8.3 million.
    The Medicines Company (NASDAQ: MDCO) shares dipped 20.9 percent to $41.62.
    Innocoll Holdings PLC (NASDAQ: INNL) shares fell 20.3 percent to $1.49. Innocoll posted a narrower-than-expected quarter loss, but revenue missed estimates. Stifel Nicolaus downgraded Innocoll from Buy to Hold.
    Rosetta Genomics Ltd. (USA) (NASDAQ: ROSG) shares declined 20.3 percent to $3.83. On Thursday, Rosetta Genomics disclosed a 1-for-12 reverse stock split.
    Esperion Therapeutics Inc (NASDAQ: ESPR) shares dropped 19.9 percent to $23.76. Esperion Therapeutics shares have jumped 106.19 percent over the past 52 weeks, while the S&P 500 index has gained 16.70 percent in the same period.
    AmTrust Financial Services Inc (NASDAQ: AFSI) tumbled 18.3 percent to $17.65. AmTrust Financial disclosed that it will delay its annual report filing for the fiscal year ended December 31, 2016.
    Qualstar Corporation (NASDAQ: QBAK) slipped 17.7 percent to $6.85. Qualstar reported a Q4 loss of $0.20 per share on revenue of $2.2 milli
  • [By Lisa Levin]

    Shares of Caleres Inc (NYSE: CAL) got a boost, shooting up 12 percent to $31.99 after the company posted upbeat Q3 earnings.

    QAD Inc. (NASDAQ: QADA) shares were also up, gaining 14 percent to $29.44 after the company posted strong Q3 results.

Best Undervalued Stocks To Invest In 2019: VEXIM EUR0.10 (VXMFF)

Advisors’ Opinion:

  • [By SEEKINGALPHA.COM]

    French medical device maker Vexim (OTC:VXMFF) contracted with an unnamed China lab to begin China registration studies for its vertebral fracture repair device, SpineJack庐. Vexim recently was granted patents for the device in China and Japan. SpineJack is an implant designed to repair a fractured vertebra and restore spinal cord balance. The 30 minute procedure is useful in 95% of vertebral fractures, according to Vexim. SpineJack was CE marked for EU use in 2010 and now is indicated for trauma and other vertebral fractures.

financial markets

June 22, 2017: Here are four stocks trading with heavy volume among 106 equities making new 52-week lows in Thursday’s session. On the NYSE, advancers led decliners by nearly 3 to 2 and on the Nasdaq, advancers led decliners by about the same ratio.

The Hain Celestial Group Inc. (NASDAQ: HAIN) posted a new 52-week low of $31.70 on Thursday, down about 4.4% compared with Wednesday’s closing price of $33.16. The stock’s 52-week high is $56.99. Volume totaled more than 12.5 million shares, about 10 times the daily average of around 1.2 million. The organic food company said this morning that an accounting review has shown that the company does not need to change its accounting practices. Shares turned positive later in the day and are on track to close up about 1%.

DDR Corp. (NYSE: DDR) dropped about 3.2% Thursday to post a new 52-week low of $8.11 after closing at $8.38 on Wednesday. The stock’s 52-week high is $19.92. Volume of nearly 12 million was about 40% higher than the daily average. The company had no specific news.

financial markets: The Michaels Companies, Inc.(MIK)

Advisors’ Opinion:

  • [By Laurie Kulikowski]

    We rate MICHAELS COS INC as a Sell with a ratings score of D+. This is driven by some concerns, which we believe should have a greater impact than any strengths, and could make it more difficult for investors to achieve positive results compared to most of the stocks we cover. Among the areas we feel are negative, one of the most important has been weak operating cash flow. 

  • [By Jim Cramer]

    After a year of stock price fluctuations, the net result is that MIK’s price has not changed very much. Although its weak earnings growth may have played a role in this flat result, don’t lose sight of the fact that the performance of the overall market, as measured by the S&P 500 Index, was essentially similar. Turning toward the future, the fact that the stock has come down in price over the past year should not necessarily be interpreted as a negative; it could be one of the factors that may help make the stock attractive down the road. Right now, however, we believe that it is too soon to buy.

     

  • [By Jim Cramer]

    The company, on the basis of net income growth from the same quarter one year ago, has significantly outperformed against the S&P 500 and exceeded that of the Specialty Retail industry average. The net income increased by 20.0% when compared to the same quarter one year prior, going from $64.00 million to $76.80 million.

     

  • [By WWW.THESTREET.COM]

    Earnings of note in the coming week include Analogic (ALOG) and Ascena Retail (ASNA) on Monday; Bojangles (BOJA) , H&R Block (HRB) , and Dick’s Sporting Goods (DKS) , Michaels (MIK) , and Urban Outfitters (URBN) on Tuesday; Ciena (CIEN) , Bankrate (RATE) , Express (EXPR) , Vera Bradley (VRA) , and Bob Evans Farms (BOBE) on Wednesday; El Pollo Loco (LOCO) , Hugo Boss (BOSSY) , Party City (PRTY) , Signet Jewelers (SIG) , and Verifone Systems (PAY) on Thursday; and Kirkland’s (KIRK) , and Vail Resorts (MTN) on Friday.

  • [By JPMorgan]

    MIK’s results over the past year point to the company’s success in improving merchandising, marketing, and in-store execution plus the benefits of having a functioning e-commerce website. We believe part of the challenge for the bears is both a lack of appreciation for the category as well as missing the historical context of how leadership has evolved. Indeed, the difference in focus on "the front end" under CEO Chuck Rubin (who arrived in 2013) vs. a more process-oriented and margin-focused CEO prior to his arrival left a lot of impactful, low hanging fruit opportunities. Finally, while we acknowledge that longer term the sustainable comp is lower than the recent ~4% underlying trend, we point to the low volatility of sales, high cash generative nature of the business, barriers to entry (e.g., high SKU density, low inventory turns, lack of brands), and MIK’s market leadership as reasons why the multiple has the potential to expand over time (a la AZO). Balance sheet de-levering should also make the PE look increasingly cheap over time and transfer cash/value to equity holders. 

  • [By Jim Cramer]

    42.37% is the gross profit margin for MICHAELS COS INC which we consider to be strong. Regardless of MIK’s high profit margin, it has managed to decrease from the same period last year. Despite the mixed results of the gross profit margin, the net profit margin of 6.57% trails the industry average.

    MICHAELS COS INC has improved earnings per share by 19.4% in the most recent quarter compared to the same quarter a year ago. This year, the market expects an improvement in earnings ($1.70 versus $1.04).

     

financial markets: Sage Therapeutics, Inc.(SAGE)

Advisors’ Opinion:

  • [By Lisa Levin]

    SAGE Therapeutics Inc (NASDAQ: SAGE) shares shot up 73 percent to $159.39 after the company disclosed that Phase 2 trial of SAGE-217 met its primary endpoint.

  • [By WWW.THESTREET.COM]

    Position: Long GLD small, bonds, SDS; short TLT small, SPY small .

  • [By Chris Lange]

    Shares of Sage Therapeutics Inc. (NASDAQ: SAGE) saw an incredible gain on Thursday after the firm announced positive top-line results from its midstage trial. Specifically, the firm reported results from its Phase 2 trial of Sage-217 for the treatment of moderate to severe major depressive disorder (MDD).

  • [By WWW.THESTREET.COM]

    The Good

    The market remains resistant (Rs over Ss and Ns). Brokerages, banks and insurance companies continue their league-leading strength. The Russell 2000 Index is up for the 15th consecutive day. Retail extends yesterday’s strength. Nordstrom (JWN) , Macy’s (M) , Best Buy (BBY) , Target (TGT) , Walmart (WMT) , Foot Locker (FL) and JCPenney (JCP) are strong. First day down for Amazon (AMZN) . Agricultural commodities are lackluster, but soybeans are up another up $0.05 today, up substantially for three days in a row. Speculative biotech (Sage (SAGE) , FibroGen (FGEN) , Acadia Pharmaceuticals (ACAD) and Aerie Pharmaceuticals  (AERI) ) stronger after recent weakness. Ag equipment up big time after the Deere (DE) beat.

    The Bad

financial markets: WildHorse Resource Development Corporation (WRD)

Advisors’ Opinion:

  • [By Paul Ausick]

    WildHorse Resource Development Corp. (NYSE: WRD) raised $413 million on the sale of $27.5 million at $15 per share, well below the expected range of $19 to $21. Shares popped just 0.4% for the day and closed the week down 0.9%.

financial markets: VEXIM EUR0.10 (VXMFF)

Advisors’ Opinion:

  • [By SEEKINGALPHA.COM]

    French medical device maker Vexim (OTC:VXMFF) contracted with an unnamed China lab to begin China registration studies for its vertebral fracture repair device, SpineJack庐. Vexim recently was granted patents for the device in China and Japan. SpineJack is an implant designed to repair a fractured vertebra and restore spinal cord balance. The 30 minute procedure is useful in 95% of vertebral fractures, according to Vexim. SpineJack was CE marked for EU use in 2010 and now is indicated for trauma and other vertebral fractures.

financial markets: Xcel Energy Inc.(XEL)

Advisors’ Opinion:

  • [By Shauna O’Brien]

    Jefferies announced on Wednesday that it has raised its rating on Xcel Energy Inc (XEL).

    The firm has upgraded XEL from “Hold” to “Buy,” and has raised the company’s price target from $31 to $32.50. This new price target suggests a 15% upside from the stock’s current price of $27.72.

    Analyst Paul B. Fremont commented: “The stock is currently trading at an 8% P/E discount to our 2015E group average multiple.”

    “Despite a difficult political environment in Minnesota the company was able to achieve a reasonable outcome in its NSP-Minnesota rate case,” the analyst added.

    Looking forward, the firm has increased its FY2014 outlook from $1.95 to $2.00 per share.

    Xcel Energy shares were mostly flat during pre-market trading Wednesday. The stock has been mostly flat YTD.

financial markets: Chiasma, Inc.(CHMA)

Advisors’ Opinion:

  • [By Lisa Levin]

    Chiasma Inc (NASDAQ: CHMA) was down, falling around 13 percent to $9.51 ahead of the U.S. Food and Drug Administration’s decision on Friday to approve or reject the company’s therapy. The status of its oral treatment for acromegaly, a capsule known as Mycapssa, will be in focus on Friday. The Street’s biotechnology expert Adam Feuerstein stated that an investor source believes the FDA will reject Chiasma’s capsules because data from a single-arm study failed to demonstrate a clinically meaningful benefit among patients.

great stocks under 10

Wall Street could hardly be quieter, with large-cap stocks in their narrowest trading range since the 1960s as the CBOE Volatility Index (VIX) continues in its longest consecutive streak below 11.

The national psyche is obsessed with the cavalcade of political news out of Washington; largely ignoring market-specific events like chatter of an OPEC-Russia supply freeze extension of a bit of softness in the housing market. Despite this, Big Tech stocks remain well bid with a narrow group of all-stars pushing the Nasdaq to a new high.

In the end, the Dow Jones Industrial Average lost a fraction, the S&P 500 lost 0.1%, the Nasdaq Composite gained 0.3% and the Russell 2000 gained 0.1%. Treasury bonds were stronger, the dollar weakened again, gold gained 0.5% and crude oil lost 0.4% as the bounce from the supply freeze extension news from earlier in the week faded on realization it will only steepen OPEC’s market share loss to U.S. shale producers.

great stocks under 10: BanColombia S.A.(CIB)

Advisors’ Opinion:

  • [By Monica Gerson]

    Bancolombia SA (ADR) (NYSE: CIB) is expected to post its quarterly earnings at $0.77 per share on revenue of $945.66 million.

    Cellcom Israel Ltd. (NYSE: CEL) is estimated to post its earnings for the latest quarter.

  • [By Javier Hasse]

    Analysts at Credit Suisse downgraded shares of Bancolombia SA (ADR) (NYSE: CIB) from Outperform to Neutral, while boosting their price target from $38 to $40.

  • [By Lisa Levin]

    Foreign Regional Banks: This industry declined 2 percent by 11:00 am with Bancolombia SA (ADR) (NYSE: CIB) moving down 3.7 percent. Bancolombia’s PEG ratio is 4.51.

great stocks under 10: VEXIM EUR0.10 (VXMFF)

Advisors’ Opinion:

  • [By SEEKINGALPHA.COM]

    French medical device maker Vexim (OTC:VXMFF) contracted with an unnamed China lab to begin China registration studies for its vertebral fracture repair device, SpineJack庐. Vexim recently was granted patents for the device in China and Japan. SpineJack is an implant designed to repair a fractured vertebra and restore spinal cord balance. The 30 minute procedure is useful in 95% of vertebral fractures, according to Vexim. SpineJack was CE marked for EU use in 2010 and now is indicated for trauma and other vertebral fractures.

great stocks under 10: Big Lots, Inc.(BIG)

Advisors’ Opinion:

  • [By Lisa Levin]

    Big Lots, Inc. (NYSE: BIG) reported better-than-expected earnings for its third quarter, and raised its FY17 guidance.

    Big Lots posted quarterly earnings of $0.06 per share on revenue of $1.111 billion. However, analysts were expecting earnings of $0.04 per share on revenue of $1.12 billion. Its comparable store sales rose 1 percent during the quarter.

  • [By Peter Graham]

    A long term performance chart shows small cap off-price or value price retailers like Five Belowand Big Lots (NYSE: BIG) along with large capRoss Stores, Inc (NASDAQ: ROST) largely moving higher in positive territoryamidstvolatility:

  • [By Peter Graham]

    A long term performance chart shows small cap off-price or value price retailers like Five Belowand Big Lots (NYSE: BIG) along with large capRoss Stores, Inc (NASDAQ: ROST) largely moving into positive territory albeit with their share of volatility:

great stocks under 10: Teck Resources Ltd(TCK)

Advisors’ Opinion:

  • [By Benzinga News Desk]

    Stephens (Equal-Weight) and Citi (Sell) both downgraded Atwood Oceanics (NYSE: ATW).

    Sell-Side's Most Noteworthy Calls
    Investec downgraded Anheuser-Busch (NYSE: BUD) to Hold.
    Deutsche Bank downgraded Freeport McMoRan (NYSE: FCX) to Hold.
    Goldman Sachs upgraded Microsoft (NASDAQ: MSFT) to Buy.
    Barclays upgraded Teck Resources (NYSE: TCK) to Overweight.
    BTIG started Adobe (NASDAQ: ADBE) at Neutral.
    Deal Talk

    U.S. oil refiner Tesoro (NYSE: TSO) said it would buy Western Refining (NYSE: WNR) for $4.1 billion to add refineries in Texas, New Mexico and Minnesota. The combined company will have refining capacity of over 1.1 million barrels per day. Tesoro has refineries in California, Washington, Alaska, Utah and North Dakota.

great stocks under 10: Chipotle Mexican Grill Inc.(CMG)

Advisors’ Opinion:

  • [By Casey Wilson]

    Unfortunately, there were a lot of disappointing companies to choose from. We picked the worst of the worst. Check out our list of the most-hated companies of 2016…

    Most-Hated Companies 2016 No. 5: Chipotle Mexican Grill Inc. (NYSE: CMG)

    Chipotle’s problems all started in July 2015 with an E. coli outbreak…

  • [By Rick Munarriz]

    Just when you thought that a return to positive comps would spell an end to the giveaways thatChipotle Mexican Grill(NYSE:CMG)sprinkled through 2016, the former fast-casual darling is back with another online game where everybody’s a winner.

  • [By Peter Graham]

    Troubled mid cap restaurant stock Chipotle Mexican Grill, Inc (NYSE: CMG) reported Q2 2017 earnings after the market closed today. Revenue was up 17.1% to $1.17 billion driven by new restaurant openings (50 new restaurants were opened during the quarter and two were closed, bringing the total restaurant count to 2,339) and an 8.1% increase in comparable restaurant sales. Comparable restaurant sales improved primarily due to an increase in customer visits, along with an increase in average check as a result of a reduction in promotional activity. Food costs were 34.1% of revenue, a decrease of 10 basis points as compared to the second quarter of 2016 ashigher avocado costs were offset by lower costs from bringing the preparation of lettuce and bell peppers back intorestaurants, as well as the benefit of menu price increases in select restaurants in the second quarter of 2017, and a decrease in paper usage and costs. Net income increased 161% to $66.7 million.

  • [By Ben Levisohn]

    Chipotle Mexican Grill (CMG) soared to the top of the S&P 500 today after M Science, a data analytics firm, predicted better same-store sales.

    Getty Images

    Chipotle Mexican Grillgained 2.8% to $407.52 today, while the S&P 500 dropped 1.2% to 2,344.02.

    Bloomberg’s Craig Giammona and Leslie Patton have the details on the M Science report:

    Chipotle Mexican Grill Inc. shares rose the most in almost six weeks after data-analysis firm M Science predicted that first-quarter sales will easily beat Wall Streets estimates, bringing a ray of optimism to a chain battered by a food-safety crisis.

    The researcher studied same-store sales during February and the first 10 days of March, according to M Science Chief Executive Officer Michael Marrale. The firm made the call based on multiple data sets and proprietary models, he said.

    Chipotle Mexican Grill’s market capitalization rose to $12.9 billion today from $11.4 billion yesterday. It reported net income of $22.9 million on sales of $3.9 billion in 2016.

  • [By Demitrios Kalogeropoulos]

    As for individual stocks, Chipotle Mexican Grill(NYSE:CMG) and iRobot (NASDAQ:IRBT) both enjoyed market-beating gains as investors reacted to fresh quarterly earnings reports.

  • [By The Ticker Tape]

    For more earnings coverage, check out what might be expected when McDonald's Corporation (NYSE: MCD) The Coca-Cola Co (NYSE: KO), and Chipotle Mexican Grill, Inc. (NYSE: CMG) report earnings tomorrow. Later in the week, tech titans Amazon.com, Inc. (NASDAQ: AMZN), Alphabet Inc (NASDAQ: GOOG) (NASDAQ: GOOGL), Microsoft Corporation (NASDAQ: MSFT) and Intel Corporation (NASDAQ: INTC) report after market close on Thursday.

great stocks under 10: Xcel Energy Inc.(XEL)

Advisors’ Opinion:

  • [By Shauna O’Brien]

    Jefferies announced on Wednesday that it has raised its rating on Xcel Energy Inc (XEL).

    The firm has upgraded XEL from “Hold” to “Buy,” and has raised the company’s price target from $31 to $32.50. This new price target suggests a 15% upside from the stock’s current price of $27.72.

    Analyst Paul B. Fremont commented: “The stock is currently trading at an 8% P/E discount to our 2015E group average multiple.”

    “Despite a difficult political environment in Minnesota the company was able to achieve a reasonable outcome in its NSP-Minnesota rate case,” the analyst added.

    Looking forward, the firm has increased its FY2014 outlook from $1.95 to $2.00 per share.

    Xcel Energy shares were mostly flat during pre-market trading Wednesday. The stock has been mostly flat YTD.

ny stock exchange today

The U.S. stock market suddenly woke up on Friday after nearly two months of sleepy sideways trading. The primary catalyst was the notion that the Fed might actually raise interest rates at their next policy meeting on September 20-21. If this is indeed the reason for the sell-off, it should not have come as a surprise to investors, as the Fed has been consistently stating since late July that a rate hike in September was on the table. Regardless of the reason, the markets have finally stirred from their prolonged slumber as they head into the weekend. What can we reasonably expect next?

Click to enlarge

ny stock exchange today: Exelon Corporation(EXC)

Advisors’ Opinion:

  • [By Casey Wilson]

    That brings us to General Electric Co. (NYSE: GE). The 125-year-old American mainstay signed a deal with Exelon Corp. (NYSE: EXC) last fall for the energy utility to use its own predictive analytics software, fittingly dubbed “Predix.”

  • [By Horizon Investments]

    For the past year, Exelon Corp. (EXC) has had a roller coaster ride, with the stock having plummeted 15% since September 2012 – the company had announced a dividend cut of 41%, which led to a drop in the share price. Separately, the recent weak PJM auction prices did not bode well for the company. However, I believe the worst is priced in the stock price, and the company’s management is committed to improving its financial flexibility and cost structure in order to strengthen its financial performance. Also, the company is planning to incur capital expenditure (CAPEX) in the upcoming years, which will result in rate base growth for Exelon.

  • [By Monica Gerson]

    Analysts are expecting Exelon Corporation (NYSE: EXC) to have earned $0.68 per share on revenue of $7.52 billion in the latest quarter. Exelon shares rose 0.34 percent to close at $35.38 on Thursday.

  • [By Monica Gerson]

    Exelon Corporation (NYSE: EXC) is expected to report its quarterly earnings at $0.68 per share on revenue of $7.52 billion.

    CST Brands Inc (NYSE: CST) is projected to report its quarterly earnings at $0.22 per share on revenue of $2.30 billion.

ny stock exchange today: VEXIM EUR0.10 (VXMFF)

Advisors’ Opinion:

  • [By SEEKINGALPHA.COM]

    French medical device maker Vexim (OTC:VXMFF) contracted with an unnamed China lab to begin China registration studies for its vertebral fracture repair device, SpineJack庐. Vexim recently was granted patents for the device in China and Japan. SpineJack is an implant designed to repair a fractured vertebra and restore spinal cord balance. The 30 minute procedure is useful in 95% of vertebral fractures, according to Vexim. SpineJack was CE marked for EU use in 2010 and now is indicated for trauma and other vertebral fractures.

ny stock exchange today: Scana Corporation(SCG)

Advisors’ Opinion:

  • [By Lisa Levin]

    In trading on Friday, utilities shares were relative laggards, down on the day by about 0.32 percent. Meanwhile, top losers in the sector included Genie Energy Ltd (NYSE: GNE), down 3 percent, and SCANA Corporation (NYSE: SCG), down 3 percent.

  • [By Lisa Levin]

    In trading on Tuesday, utilities shares rose by just 0.1 percent. Meanwhile, top losers in the sector included Atlantic Power Corp (NYSE: AT), down 2 percent, and SCANA Corporation (NYSE: SCG) down 1 percent.

  • [By Lisa Levin]

    In trading on Monday, utilities shares were relative laggards, down on the day by about 0.43 percent. Meanwhile, top losers in the sector included SCANA Corporation (NYSE: SCG), down 2 percent, and FirstEnergy Corp. (NYSE: FE), down 2 percent.

ny stock exchange today: Tandy Leather Factory, Inc.(TLF)

Advisors’ Opinion:

  • [By Lee Jackson]

    These companies also reported insider buying last week: Armour Residential REIT Inc. (NYS